A Biomarker Study in Patients with GBA1‐Parkinson's Disease and Healthy Controls

JM den Heijer, VC Cullen, DR Pereira… - Movement …, 2023 - Wiley Online Library
Background Molecules related to glucocerebrosidase (GCase) are potential biomarkers for
development of compounds targeting GBA1‐associated Parkinson's disease (GBA‐PD) …
被引用次数：8 相关文章

A Biomarker Study in Patients with GBA1-Parkinson's Disease and Healthy Controls

JM den Heijer, VC Cullen… - … : official journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Molecules related to glucocerebrosidase (GCase) are potential biomarkers for
development of compounds targeting GBA1-associated Parkinson's disease (GBA-PD) …

A Biomarker Study in Patients with GBA1-Parkinson's Disease and Healthy Controls.

JM den Heijer, VC Cullen, DR Pereira… - … : Official Journal of the …, 2023 - europepmc.org
Background Molecules related to glucocerebrosidase (GCase) are potential biomarkers for
development of compounds targeting GBA1-associated Parkinson's disease (GBA-PD) …
[PDF] universiteitleiden.nl

[PDF][PDF] A Biomarker Study in Patients with GBA1-Parkinson's Disease and Healthy Controls

JM den Heijer, VC Cullen… - Movement …, 2023 - scholarlypublications …
Background: Molecules related to glucocerebrosidase (GCase) are potential biomarkers for
development of compounds targeting GBA1-associated ParkinsonLs disease (GBA-PD) …

A biomarker study in patients with GBA1-parkinson's disease and healthy controls

JM den Heijer, VC Cullen… - Movement …, 2023 - scholarlypublications …
BackgroundMolecules related to glucocerebrosidase (GCase) are potential biomarkers for
development of compounds targeting GBA1-associated Parkinson's disease (GBA-PD) …